| Title | Inflammopharmacology |
| Abbreviation | Inflammopharmacology |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (Q1); Pharmacology (medical) (Q1); Immunology (Q2) |
| h-index | 74 |
| Overall Rank/Ranking | 3214 |
| SCImago Journal Rank (SJR) | 1.269 |
| Impact Score | 5.72 |
| Publisher | Springer Science and Business Media Deutschland GmbH |
| Country | Switzerland |
| ISSN | 09254692, 15685608 |
| Best Quartile | Q1 |
| Coverage History | 1991-2025 |
Inflammopharmacology is a journal covering the technologies/fields/categories related to Pharmacology (Q1); Pharmacology (medical) (Q1); Immunology (Q2). It is published by Springer Science and Business Media Deutschland GmbH. The overall rank of Inflammopharmacology is 3214. According to SCImago Journal Rank (SJR), this journal is ranked 1.269. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 74. The best quartile for this journal is Q1.
The ISSN of Inflammopharmacology journal is 09254692, 15685608. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Inflammopharmacology is cited by a total of 3205 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Inflammopharmacology is 5.72, which is computed in 2025 as per its definition. Inflammopharmacology IF is increased by a factor of 1.07 and approximate percentage change is 23.01% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Inflammopharmacology is 5.72. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5.72 |
| 2023 | 4.65 |
| 2022 | 5.28 |
| 2021 | 4.58 |
| 2020 | 4.09 |
| 2019 | 3.11 |
| 2018 | 3.39 |
| 2017 | 3.33 |
| 2016 | 2.97 |
| 2015 | 2.75 |
| 2014 | 3.79 |
Inflammopharmacology has an h-index of 74. It means 74 articles of this journal have more than 74 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Inflammopharmacology is 09254692, 15685608. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Inflammopharmacology is 3214. According to SCImago Journal Rank (SJR), this journal is ranked 1.269. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.269 |
| 2023 | 0.952 |
| 2022 | 0.932 |
| 2021 | 0.772 |
| 2020 | 0.945 |
| 2019 | 0.729 |
| 2018 | 0.894 |
| 2017 | 0.925 |
| 2016 | 0.941 |
| 2015 | 1.031 |
| 2014 | 1.056 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 3214 |
| 2023 | 4838 |
| 2022 | 4714 |
| 2021 | 6041 |
| 2020 | 4759 |
| 2019 | 6650 |
| 2018 | 5084 |
| 2017 | 4859 |
| 2016 | 4786 |
| 2015 | 4260 |
| 2014 | 4002 |
Inflammopharmacology is published by Springer Science and Business Media Deutschland GmbH. It's publishing house is located in Switzerland. Coverage history of this journal is as following: 1991-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Inflammopharmacology is Inflammopharmacology. This abbreviation ('Inflammopharmacology') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (Q1); Pharmacology (medical) (Q1); Immunology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Inflammopharmacology latest impact IF is 5.72. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 5.72 (2024) and 2.75 (2015), respectively, in the last 11 years. Moreover, its average IS is 3.97 in the previous 11 years.
The Inflammopharmacology has an SJR (SCImago Journal Rank) of 1.269, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.269 in 2024 and the lowest being 0.729 in 2019. Furthermore, the average SJR of the Inflammopharmacology over the previous 11-year period stands at 3.97.
The latest h-index of the Inflammopharmacology is 74.
The Inflammopharmacology is published by the Springer Science and Business Media Deutschland GmbH, with its country of publication being the Switzerland.
The Inflammopharmacology is currently ranked 3214 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3214 in 2024 and its lowest position of 6650 in 2019.
The standard ISO4 abbreviation for the Inflammopharmacology is Inflammopharmacology.
Inflammopharmacology is classified as a journal that the Springer Science and Business Media Deutschland GmbH publishes.
The Inflammopharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Inflammopharmacology is assigned the following International Standard Serial Numbers (ISSN): 09254692, 15685608.
The best quartile for the Inflammopharmacology is Q1 (2024).
The Inflammopharmacology coverage history can be summarized as follows: 1991-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Milan Journal of Mathematics | journal | 5131 | Birkhauser Verlag Basel | 31 | 0.74 |
| Entrepreneurship Theory and Practice | journal | 168 | SAGE Publications Ltd | 212 | 13.35 |
| World Englishes | journal | 7267 | Wiley-Blackwell | 68 | 2.38 |
| Journal of Education and Work | journal | 8987 | Brill Academic Publishers | 47 | 2.08 |
| European Journal of Education | journal | 4974 | Wiley-Blackwell Publishing Ltd | 63 | 5.08 |
| Howard Journal of Communications | journal | 14582 | Taylor and Francis Ltd. | 42 | 1.27 |
| Studies in Continuing Education | journal | 4850 | Routledge | 44 | 3.35 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10600 | Schweizerbart Science Publishers | 18 | 4.25 |
| Journal of Imaging Science and Technology | journal | 22021 | Society for Imaging Science and Technology | 45 | 0.61 |
| Transboundary and Emerging Diseases | journal | 5531 | John Wiley and Sons Ltd | 92 | 3.26 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 5.72 |
| 2023 | 4.65 |
| 2022 | 5.28 |
| 2021 | 4.58 |
| 2020 | 4.09 |
| 2019 | 3.11 |
| 2018 | 3.39 |
| 2017 | 3.33 |
| 2016 | 2.97 |
| 2015 | 2.75 |
| 2014 | 3.79 |
